Alice Wyse Jackson

Senior Director, Medical Affairs

Role: Senior Director, Medical Affairs at Stoke Therapeutics
Location: Seattle, WA, US
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Alice Wyse Jackson

Fellowship-trained pharmaceutical professional with deep Medical Affairs experience across rare diseases, epilepsy, and ophthalmology. Currently leading Global Medical Operations, Information & Analytics, building the infrastructure, analytics, and communication frameworks that enable consistent, high-quality scientific exchange and leadership-ready insights across the organization.Previously led Medical Affairs in the Western U.S. for Dravet syndrome and continue to work globally on ADOA, partnering closely with investigators and care teams to advance innovative therapies. Recognized for clear, impactful scientific communication (14 publications and multiple presentation awards) and strong cross-functional collaboration, with a focus on translating science into strategy and meaningful impact for patients.

Experience

Senior Director, Medical Affairs
Stoke Therapeutics
Aug 2024 — Present

Education

University College Cork
Doctor of Philosophy (PhD), Ophthalmology and Neurological Drug Development
Trinity College Dublin
Bachelor of Science - BS, Neuroscience

Skills

Facs Analysis
Apoptosis
Scientific Review
Neurodegeneration
Science
Dissection
Biochemistry
Flow Cytometry
Transfection
Healthcare
Immunofluorescence
Laboratory
Biotechnology
Mammalian Cell Culture
Mouse Handling
Cryosectioning
Microsoft Office
Genetic Mouse Models
Mouse Models
Polymerase Chain Reaction (Pcr)
Statistical Data Analysis
In Vitro
Mtt
Rt-Pcr
Ex Vivo
Cell Biology
Scientific Analysis
Microscopy
Systems Neuroscience
Scientific Presentation
Retina
Scientific Papers
Scientific Writing
Data Analysis
Working with Physicians
Neuroscience
Western Blotting
Life Sciences
Sirna
Pharmacology

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@stoketherapeutics.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Stoke Therapeutics

Biotechnology Research · 235 employees · Founded 2017 · Bedford, Massachusetts, United States

Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/.

stoketherapeutics.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.